-
2
-
-
0003319434
-
Mucosal injury caused by drugs, chemicals and stress
-
Haubrich WS, Schaffner F, Berk JE, eds. Philadelphia: WB Saunders
-
(1994)
th edn.
, vol.2
, pp. 656-699
-
-
Hawkey, C.J.1
Hudson, N.2
-
4
-
-
0028327671
-
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
-
(1994)
Lancet
, vol.343
, pp. 769-772
-
-
Garcia Rodriguez, L.A.1
Jick, H.2
-
5
-
-
8944227048
-
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
-
(1996)
BMJ
, vol.312
, pp. 1563-1566
-
-
Henry, D.1
Lim, L.-Y.2
Garcia Rodriguez, L.A.3
-
10
-
-
0032476571
-
Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus
-
(1998)
Am J Med
, vol.105
-
-
Bjorkman, D.1
-
13
-
-
0033428385
-
Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
-
(1999)
Am J Med
, vol.107
-
-
Brater, D.C.1
-
20
-
-
0006242136
-
-
GPRD. Data presented to FDA hearings. 8 February 2001
-
-
-
-
21
-
-
0015237292
-
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
-
(1971)
Nat New Biol
, vol.231
, pp. 232-235
-
-
Vane, J.R.1
-
30
-
-
0001023001
-
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
-
The International Consensus Meeting on the Mode of Action of COX-2 Inhibition, 5-6 December 1997
-
(1999)
Rheumatology
, vol.38
, pp. 779-788
-
-
Brooks, P.1
Emery, P.2
Evans, J.F.3
-
31
-
-
0033594911
-
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
-
published erratum appears in Proc Natl Acad Sci U S A 1999;96:9666
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 7563-7568
-
-
Warner, T.D.1
Giuliano, F.2
Vojnovic, I.3
-
36
-
-
0033799852
-
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin
-
(2000)
Gut
, vol.47
, pp. 527-532
-
-
Sigthorsson, G.1
Crane, R.2
Simon, T.3
-
38
-
-
0032851480
-
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
-
(1999)
Gastroenterology
, vol.117
, pp. 776-783
-
-
Laine, L.1
Harper, S.2
Simon, T.3
-
39
-
-
0034121667
-
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
-
(2000)
Arthritis Rheum
, vol.43
, pp. 370-377
-
-
Hawkey, C.1
Laine, L.2
Simon, T.3
-
42
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs nonsteroidol anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib long-term arthritis safety study
-
(2000)
JAMA
, vol.284
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
-
43
-
-
0031680203
-
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor. Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1591-1602
-
-
Simon, L.S.1
Lanza, F.L.2
Lipsky, P.E.3
-
44
-
-
0033601089
-
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
-
(1999)
JAMA
, vol.282
, pp. 1921-1928
-
-
Simon, L.S.1
Weaver, A.L.2
Graham, D.Y.3
-
45
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and reumatoid arthritis: The CLASS study: A randomized controlled trial
-
(2000)
JAMA
, vol.284
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
-
46
-
-
0006242137
-
-
Merck. Data presented to FDA Ft
-
-
-
-
47
-
-
0030787414
-
Consumption of non-steroidal anti-inflammatory drugs and the development of functianal renal impairment in elderly subjects. Results of a case-control study
-
(1997)
Br J Clin Pharmacol
, vol.44
, pp. 85-90
-
-
Henry, D.1
Page, J.2
Whyte, I.3
-
48
-
-
0343184105
-
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem
-
(2000)
Arch Intern Med
, vol.160
, pp. 777-784
-
-
Page, J.1
Henry, D.2
-
55
-
-
0035286901
-
Cyclooxygenase-1 specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
-
(2001)
Am J Ther
, vol.8
, pp. 85-95
-
-
Whelton, A.1
Fort, J.G.2
Puma, J.A.3
-
59
-
-
0029866403
-
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers
-
(1996)
Br J Rheumatol
, vol.35
, pp. 61-67
-
-
Patoia, L.1
Santucci, L.2
Furno, P.3
-
61
-
-
0031685519
-
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
-
International MELISSA study group. Meloxicam large-scale international study safety assessment
-
(1998)
Br J Rheumatol
, vol.37
, pp. 937-945
-
-
Hawkey, C.1
Kahan, A.2
Steinbruck, K.3
-
62
-
-
0031696493
-
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis
-
(1998)
Br J Rheumatol
, vol.37
, pp. 946-951
-
-
Dequeker, J.1
Hawkey, C.2
Kahan, A.3
-
64
-
-
0033919207
-
The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam
-
(2000)
Pharmacotherapy
, vol.20
, pp. 741-744
-
-
Jick, S.S.1
-
67
-
-
0021803847
-
Long-term evaluation of the efficacy and safety of etodolac in the treatment of rheumatoid arthritis
-
(1985)
Adv Ther
, vol.2
, pp. 82-95
-
-
Jacob, G.1
-
69
-
-
0027481411
-
Double-blind comparison of etodolac sustained-release tablets and diclofenac sustained-release tablets in patients with rheumatoid arthritis
-
(1993)
Curr Ther Res Clin Exp
, vol.53
, pp. 144-153
-
-
Porzio, F.1
-
70
-
-
0031050476
-
Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis
-
Etodolac Study 326, Rheumatoid Arthritis Investigators Group
-
(1997)
J Rheumatol Suppl
, vol.47
, pp. 10-16
-
-
Lightfoot, R.1
-
72
-
-
0031049443
-
Comparison of etodolac and piroxicam in patients with osteoarthritis of the hip or knee: A prospective, randomised, double-blind, controlled multicentre study
-
(1997)
Clin Drug Invest
, vol.13
, pp. 66-75
-
-
Rogind, H.1
|